ESC guidance for managing cardiovascular disease during COVID-19

Clinical Trials & Research

Leading experts treating COVID-19 patients provide advice on managing cardiovascular disease during the pandemic. The European Society of Cardiology (ESC) guidance is published online.

The novel coronavirus not only causes viral pneumonia but also has major implications for the cardiovascular system.

Heart and stroke patients are more likely to have severe cases of COVID-19, as are people with risk other factors, including advanced age, diabetes, hypertension and obesity.

In addition, COVID-19 patients may develop heart damage, which raises their chance of dying.

You Might Like

This detailed document provides healthcare professionals the best available knowledge, based on practical experience, on how to diagnose and manage cardiovascular conditions in COVID-19 patients, treat the coronavirus infection, and organize and prioritize care. It will be updated as more evidence is gathered.

Articles You May Like

Diabetes WA calls for greater recognition of diabetes impact on Aboriginal Communities
Ask Mayo Clinic: Cystic Fibrosis
Tulane receives up to $16 million to move nasal pneumonia vaccine from the lab to clinical trials
‘Urgent threat’: CDC warns against Candida auris, a drug-resistant fungus invading health care facilities
Evidence Based Homoeopathic Treatment of Plaque Psoriasis

Leave a Reply

Your email address will not be published. Required fields are marked *